Follow us twitter facebook
Edition: Global
Click here to subscribe toour free weekly newsletter click here
Industry buzz

French health authorities partially suspend Cargill production activities in Lanillis

Following an inspection conducted in July 2015, the French National Agency for Medicines and Health Products Safety (ANSM) has suspended the production of alginic acid and alginates for pharmaceutical, personal care or medical device applications, at Cargill’s Lannilis facility in France.

According to ANSM, the manufacturing process does not comply with regulations applicable to materials that are intended to be used in pharmaceutical and cosmetic products. [1] Among others, the ANSM pointed out “the lack of cleanliness of the manufacturing environment,” “insufficient cleaning procedures,” “the lack of adequate records of production batches,” as well as the absence of the required authorization for the production of alginic acid.

In July, 2015, ANSM undertook a scheduled inspection of our alginate plant in Lannilis, France and raised considerations regarding the manufacturing process of alginic acid and alginates for pharmaceutical and personal care or medical device applications. Cargill is disappointed with this result and is investigating its legal options as we consider this decision out of proportion. We reiterate that all of our products consistently undergo quality control before shipping. We are convinced that all products shipped from Lannilis were and are in compliance with the specifications agreed with our customers,” a spokeswoman for Cargill told Premium Beauty News.

ANSM required Cargill customers to withdraw from the market all the products containing the concerned ingredients or to perform analyses demonstrating for each product the absence of any risk to human health.

We will continue to address the concerns of the authorities and ensure our processes comply with all necessary regulations. We regret and apologize for the inconveniences this situation generates and are committed to do our utmost to address the needs of our customers. Even if we are convinced that all products shipped from Lannilis were and are in compliance with the mutually agreed specifications - we have taken immediate actions to improve our procedures for the health products (pharmaceutical, medical devices and personal care) and also took the initiative to suspend the health production lines (pharmaceutical excipient, medical devices and personal care) and deliveries until we had more clarity on the final decision of the ANSM,” added Cargill.

ANSM - Decision of September 25, 2015

ANSM - Decision of September 25, 2015

Footnotes

[1] Decision of 25 September 2015, published in the Official Journal of the French Republic of 1st October 2015

© 2015 - Premium Beauty News - www.premiumbeautynews.com
latest news
Focus
spip-vignette

A new trade show dedicated to clean beauty in London

Dubbed Clean Beauty in London the new trade show intends to gather experts, scientists, suppliers, brands, influencers and journalists under one roof “to build the future of clean beauty.” Taking place on October 12 & 13, 2020 at The Brewery, located at 52 Chiswell Street at the heart of London, the event aims to encourage (...)

read more
job opportunities
Experts’ views
The rise of indie French Touch - Three favorites from the “Made in France” Exhibition

Cosmetics Inspiration & Creation
The rise of indie French Touch - Three favorites from the “Made in France” Exhibition

Who said “Indie” only came from the US? French Beauty brands are blooming with a renewed creativity, disrupting the indie game with the French savoir-faire. Beauty trends and marketing firm Inspiration & Creation has selected their three favorites from the last edition of the ‘Made in France’ show. Vive la Révolution! American indie (...)

read more

Features

We use cookies to give you a better browsing experience. By continuing your visit to this site, you accept the use of cookies. Read more and set cookies
close